Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

The Revolution in Migraine Genetics: From Aching Channels Disorders to a Next-Generation Medicine.

Pellacani S, Sicca F, Di Lorenzo C, Grieco GS, Valvo G, Cereda C, Rubegni A, Santorelli FM.

Front Cell Neurosci. 2016 Jun 13;10:156. doi: 10.3389/fncel.2016.00156. eCollection 2016. Review.

2.

Early-onset familial hemiplegic migraine due to a novel SCN1A mutation.

Fan C, Wolking S, Lehmann-Horn F, Hedrich UB, Freilinger T, Lerche H, Borck G, Kubisch C, Jurkat-Rott K.

Cephalalgia. 2016 Jan 12. pii: 0333102415608360. [Epub ahead of print]

3.

Genetic studies of Polish migraine patients: screening for causative mutations in four migraine-associated genes.

Domitrz I, Kosiorek M, Żekanowski C, Kamińska A.

Hum Genomics. 2016 Jan 8;10:3. doi: 10.1186/s40246-015-0057-8.

4.

Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels.

Miceli F, Soldovieri MV, Ambrosino P, De Maria M, Manocchio L, Medoro A, Taglialatela M.

Front Cell Neurosci. 2015 Jul 15;9:259. doi: 10.3389/fncel.2015.00259. eCollection 2015. Review.

5.

Familial hemiplegic migraine and spreading depression.

Kazemi H, Speckmann EJ, Gorji A.

Iran J Child Neurol. 2014 Summer;8(3):6-11. Review.

6.

Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies.

Carreño O, Corominas R, Serra SA, Sintas C, Fernández-Castillo N, Vila-Pueyo M, Toma C, Gené GG, Pons R, Llaneza M, Sobrido MJ, Grinberg D, Valverde MÁ, Fernández-Fernández JM, Macaya A, Cormand B.

Mol Genet Genomic Med. 2013 Nov;1(4):206-22. doi: 10.1002/mgg3.24. Epub 2013 Jul 2.

7.

NaV1.1 channels in axon initial segments of bipolar cells augment input to magnocellular visual pathways in the primate retina.

Puthussery T, Venkataramani S, Gayet-Primo J, Smith RG, Taylor WR.

J Neurosci. 2013 Oct 9;33(41):16045-59. doi: 10.1523/JNEUROSCI.1249-13.2013.

8.

Sodium overload due to a persistent current that attenuates the arrhythmogenic potential of a novel LQT3 mutation.

Moreau A, Krahn AD, Gosselin-Badaroudine P, Klein GJ, Christé G, Vincent Y, Boutjdir M, Chahine M.

Front Pharmacol. 2013 Oct 1;4:126. doi: 10.3389/fphar.2013.00126. eCollection 2013.

9.

Neurological perspectives on voltage-gated sodium channels.

Eijkelkamp N, Linley JE, Baker MD, Minett MS, Cregg R, Werdehausen R, Rugiero F, Wood JN.

Brain. 2012 Sep;135(Pt 9):2585-612. doi: 10.1093/brain/aws225. Review.

10.

Migraine headache: a review of the molecular genetics of a common disorder.

Di Lorenzo C, Grieco GS, Santorelli FM.

J Headache Pain. 2012 Oct;13(7):571-80. doi: 10.1007/s10194-012-0478-x. Epub 2012 Sep 1. Review.

11.

Increased expression of sodium channel subunit Nav1.1 in the injured dorsal root ganglion after peripheral nerve injury.

Wang W, Atianjoh F, Gauda EB, Yaster M, Li Y, Tao YX.

Anat Rec (Hoboken). 2011 Aug;294(8):1406-11. doi: 10.1002/ar.21437. Epub 2011 Jun 28.

12.

Pain as a channelopathy.

Raouf R, Quick K, Wood JN.

J Clin Invest. 2010 Nov;120(11):3745-52. doi: 10.1172/JCI43158. Epub 2010 Nov 1. Review.

13.

Sodium channel blockers for the treatment of neuropathic pain.

Bhattacharya A, Wickenden AD, Chaplan SR.

Neurotherapeutics. 2009 Oct;6(4):663-78. doi: 10.1016/j.nurt.2009.08.001. Review.

14.

Cortical spreading depression-new insights and persistent questions.

Charles A, Brennan K.

Cephalalgia. 2009 Oct;29(10):1115-24. doi: 10.1111/j.1468-2982.2009.01983.x.

Supplemental Content

Support Center